These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 3692080)

  • 1. Physiological, pharmacological and pathological factors affecting the pharmacokinetics of calcium entry blockers.
    Padrini R; Piovan D; Bova S; Moretto R; Cargnelli G; Ferrari M
    G Ital Cardiol; 1987 Sep; 17(9):786-90. PubMed ID: 3692080
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacology of calcium antagonists].
    Zannad F
    Rev Prat; 1988 Nov; 38(27):1965-70. PubMed ID: 3264617
    [No Abstract]   [Full Text] [Related]  

  • 3. [Interaction between calcium antagonists and digoxin].
    Christensen C
    Ugeskr Laeger; 1991 Apr; 153(17):1180-4. PubMed ID: 2028527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on calcium-channel blocking agents.
    Talbert RL; Bussey HI
    Clin Pharm; 1983; 2(5):403-16. PubMed ID: 6354566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
    Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
    Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical pharmacology of calcium inhibitors].
    Singlas E; Martre H; Taburet AM
    Arch Mal Coeur Vaiss; 1985 Nov; 78 Spec No():15-22. PubMed ID: 3937500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of calcium antagonists in patients with renal failure.
    Rahn KH; van Bortel LM; Mooy JM
    J Hypertens Suppl; 1987 Dec; 5(4):S67-9. PubMed ID: 3481636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacokinetics and -dynamics of calcium antagonists in the elderly].
    Spahn-Langguth H; Möhrke W; Mutschler E; Platt D
    Fortschr Med; 1993 Oct; 111(28):441-5. PubMed ID: 8282288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetics of calcium antagonists].
    Richard MO
    Therapie; 1993; 48 Spec No():651-7. PubMed ID: 8091350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of calcium entry blockers in several models of immediate hypersensitivity.
    Ritchie DM; Sierchio JN; Bishop CM; Hedli CC; Levinson SL; Capetola RJ
    J Pharmacol Exp Ther; 1984 Jun; 229(3):690-5. PubMed ID: 6202868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal differences in actions of calcium channel blockers on K+ accumulation, cardiac function, and high-energy phosphate levels in ischemic guinea pig hearts.
    Sato R; Yamazaki J; Nagao T
    J Pharmacol Exp Ther; 1999 May; 289(2):831-9. PubMed ID: 10215660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitor effects of diltiazem, nicardipine, nifedipine and verapamil on the norepinephrine-induced contractions of the canine saphenous vein in calcium-free medium.
    Saïag B; Milon D; Bentue-Ferrer D; Allain H; Rault B; Van den Driessche J
    Res Commun Chem Pathol Pharmacol; 1994 Mar; 83(3):255-69. PubMed ID: 8008975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbamazepine and L-type calcium channel inhibitors: a binding assay study.
    Ngan ET; Vincent SR
    Biol Psychiatry; 1996 Jun; 39(11):979-81. PubMed ID: 9162212
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of nifedipine, verapamil and diltiazem on serum biochemical parameters and aortic composition of atherosclerotic chickens.
    García-Pérez B; Ayala I; Castells MT; Doménech G; Sánchez-Polo MT; García-Partida P; Valdés M
    Biomed Pharmacother; 2005; 59(1-2):1-7. PubMed ID: 15740928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro percutaneous absorption of verapamil.
    Jain GK; Agrawal SS
    Indian J Exp Biol; 1996 May; 34(5):475-7. PubMed ID: 9063080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of diltiazem and other calcium entry blockers.
    Hermann P; Morselli PL
    Acta Pharmacol Toxicol (Copenh); 1985; 57 Suppl 2():10-20. PubMed ID: 3904330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of calcium entry blockers on coronary constriction and myocardial ischemia due to leukotriene D4.
    Ezra D; Boyd LM; Goldstein RE; Feuerstein G
    J Pharmacol Exp Ther; 1985 Apr; 233(1):229-34. PubMed ID: 3981457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of the calcium-channel blocker diltiazem after a single intravenous dose in horses.
    Schwarzwald CC; Sams RA; Bonagura JD
    J Vet Pharmacol Ther; 2006 Jun; 29(3):165-71. PubMed ID: 16669860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of calcium antagonists on leukotriene D4-induced contractions of the guinea-pig trachea and lung parenchyma.
    Weichman BM; Muccitelli RM; Tucker SS; Wasserman MA
    J Pharmacol Exp Ther; 1983 May; 225(2):310-5. PubMed ID: 6842394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Slow infusion of calcium channel blockers compared with intravenous adenosine in the emergency treatment of supraventricular tachycardia.
    Lim SH; Anantharaman V; Teo WS; Chan YH
    Resuscitation; 2009 May; 80(5):523-8. PubMed ID: 19261367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.